A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer Journal Article


Authors: Vidal, S.; Rodriguez Bravo, V.; Quinn, S.; Rodriguez-Barrueco, R.; Lujambio, A.; Williams, E.; Sun, X.; delaIglesia-Vicente, J.; Lee, A.; Readhead, B.; Chen, X.; Galsky, M.; Esteve, B.; Petrylak, D.; Dudley, J.; Rabadan, R.; Silva, J.; Hoshida, Y.; Lowe, S.; Cordon-Cardo, C.; Domingo-Domenech, J.
Article Title: A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer
Abstract: Elucidating the determinants of aggressiveness in lethal prostate cancer may stimulate therapeutic strategies that improve clinical outcomes. We used experimental models and clinical databases to identify GATA2 as a regulator of chemotherapy resistance and tumorigenicity in this context. Mechanistically, direct upregulation of the growth hormone IGF2 emerged as a mediator of the aggressive properties regulated byGATA2. IGF2 in turn activated IGF1R and INSR as well as a downstream polykinase program. The characterization of this axis prompted a combination strategy whereby dual IGF1R/INSR inhibition restored the efficacy of chemotherapy and improved survival in preclinical models. These studies reveal a GATA2-IGF2 aggressiveness axis in lethal prostate cancer and identify a therapeutic opportunity in this challenging disease.
Keywords: signal transduction; cancer chemotherapy; cancer survival; controlled study; human tissue; major clinical study; cancer growth; drug efficacy; nonhuman; gene expression; tumor volume; animal experiment; animal model; data base; docetaxel; clinical study; carcinogenicity; somatomedin b; circulating tumor cell; castration resistant prostate cancer; receptor upregulation; cabazitaxel; transcription factor gata 2; linsitinib; human; male; priority journal; article
Journal Title: Cancer Cell
Volume: 27
Issue: 2
ISSN: 1535-6108
Publisher: Cell Press  
Date Published: 2015-02-09
Start Page: 223
End Page: 239
Language: English
DOI: 10.1016/j.ccell.2014.11.013
PROVIDER: scopus
PUBMED: 25670080
PMCID: PMC4356948
DOI/URL:
Notes: Export Date: 2 March 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics